ConductScience.org, home

Paper30408564

Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.

Raj K and 24 others. Biol Blood Marrow Transplant, 2019. Cited by 50 papers, by iCite.

Cite this record

ConductScience Library. Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation. Papers, record 30408564. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/30408564

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Family Mismatched Allogeneic Stem Cell Transplantation for Myelofibrosis: Report from the Chronic Malignancies Working Party of European Society for Blood and Marrow Transplantation.
PubMed
Journal
Biol Blood Marrow Transplant
PubMed
Year
2019
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
50
iCite
Relative citation ratio, by iCite
2.33
iCite
Revised in PubMed
2020-01-28
PubMed

Authors25

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Raj KKavita
2Eikema DJDiderik-Jan
3McLornan DPDonal P
4Olavarria EEduardo
5Blok HJHenric-Jan
6Bregante SStefania
7Ciceri FFabio
8Passweg JJakob
9Ljungman PPer
10Schaap NNicolaas
11Carlson KKristina
12Zuckerman TTsila
13de Wreede LCLiesbeth C
14Volin LLiisa
15Koc YYener
16Diez-Martin JLJose Luis
17Brossart PPeter
18Wolf DDominik
19Blaise DDidier
20Bartolomeo PDPaolo Di

Source PubMed

See all 25 authorsDownload CSV of authors

Topics22

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
FamilyMajor topic
Hematopoietic Stem Cell TransplantationMajor topic
HistocompatibilityMajor topic
Primary MyelofibrosisMajor topic
Adult
Aged
Bone Marrow Transplantation
Databases, Factual
Europe
Female
Graft Survival
Graft vs Host Disease
Humans
Male
Middle Aged
Peripheral Blood Stem Cell Transplantation
Recurrence
Retrospective Studies
Societies, Medical
Survival Analysis
Transplantation Conditioning
Transplantation, Homologous

Source PubMed

Download CSV of topics

Cited by28

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.

PMIDTitleJournalYearIn PapersSource
41537336Platelet recovery delay and survival in patients with myelofibrosis undergoing allogeneic hemopoietic stem cell transplantation.Haematologica2026https://conductscience.org/library/papers/41537336PubMed
40879525Impact of Donor Type on Outcomes After Allogeneic Hematopoietic Cell Transplantation in Myelofibrosis: A Study on Behalf of the Chronic Malignancies Working Party of the EBMT.Am J Hematol2025https://conductscience.org/library/papers/40879525PubMed
38916866Donor types and outcomes of transplantation in myelofibrosis: a CIBMTR study.Blood Adv2024https://conductscience.org/library/papers/38916866PubMed
38773281Anti-T-lymphocyte globulin improves GvHD-free and relapse-free survival in myelofibrosis after matched related or unrelated donor transplantation.Bone Marrow Transplant2024https://conductscience.org/library/papers/38773281PubMed
38378917Comparison of haploidentical transplantation and single cord blood transplantation for myelofibrosis.Bone Marrow Transplant2024https://conductscience.org/library/papers/38378917PubMed
38066916Are transplant indications changing for myelofibrosis?Hematology Am Soc Hematol Educ Program2023https://conductscience.org/library/papers/38066916PubMed
37637037Characterization of engraftment dynamics in myelofibrosis after allogeneic hematopoietic cell transplantation including novel conditioning schemes.Front Oncol2023https://conductscience.org/library/papers/37637037PubMed
37601853Advances in management of primary myelofibrosis and polycythaemia vera: Implications in clinical practice.EJHaem2023https://conductscience.org/library/papers/37601853PubMed
36959692Allogeneic Hematopoietic Stem Cell Transplantation for Primary Myelofibrosis: A 20-year Experience in a Single CenterBalkan Med J2023https://conductscience.org/library/papers/36959692PubMed
36861402Momelotinib (JAK1/JAK2/ACVR1 inhibitor): mechanism of action, clinical trial reports, and therapeutic prospects beyond myelofibrosis.Haematologica2023https://conductscience.org/library/papers/36861402PubMed
35455686The Use of Allogeneic Hematopoietic Stem Cell Transplantation in Primary Myelofibrosis.J Pers Med2022https://conductscience.org/library/papers/35455686PubMed
35419771Improving allogeneic stem cell transplantation in myelofibrosis.Int J Hematol2022https://conductscience.org/library/papers/35419771PubMed
35159362How We Manage Myelofibrosis Candidates for Allogeneic Stem Cell Transplantation.Cells2022https://conductscience.org/library/papers/35159362PubMed
35158092Post-Transplantation Cyclophosphamide-Based Graft- versus-Host Disease Prophylaxis with Nonmyeloablative Conditioning for Blood or Marrow Transplantation for Myelofibrosis.Transplant Cell Ther2022https://conductscience.org/library/papers/35158092PubMed
34911786Myelofibrosis: Genetic Characteristics and the Emerging Therapeutic Landscape.Cancer Res2022https://conductscience.org/library/papers/34911786PubMed
34889421Novel therapies vs hematopoietic cell transplantation in myelofibrosis: who, when, how?Hematology Am Soc Hematol Educ Program2021https://conductscience.org/library/papers/34889421PubMed
34663912Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study.Leukemia2022https://conductscience.org/library/papers/34663912PubMed
345362932021 Update on allogeneic hematopoietic stem cell transplant for myelofibrosis: A review of current data and applications on risk stratification and management.Am J Hematol2021https://conductscience.org/library/papers/34536293PubMed
34052505Outcomes of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis-A Systematic Review and Meta-Analysis.Transplant Cell Ther2021https://conductscience.org/library/papers/34052505PubMed
34017327Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021.Front Immunol2021https://conductscience.org/library/papers/34017327PubMed

See all 28 cited byDownload CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD34947PubTator's text mininghttps://conductscience.org/library/genes/947NCBI Gene
HLA-A3105PubTator's text mininghttps://conductscience.org/library/genes/3105NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/30408564

GET https://conductscience.org/api/papers/v1/30408564/authors?page=2